公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2015 | Serum viral load is not the major determinant of hepatocellular carcinoma risk in chronic hepatitis B patients with compensated liver cirrhosis | Tseng, Tai-Chung; Liu, Chun-Jen; Yang, Wan-Ting; Yang, Hung-Chih; Chen, Chi-Ling; Su, Tung-Hung; Kao, Jia-Horng | J. Gastroenterol. Hepatol. | | | |
2015 | Serum viral load is not the major determinant of hepatocellular carcinoma risk in chronic hepatitis B patients with compensated liver cirrhosis | Tseng, Tai-Chung; Liu, Chun-Jen; Yang, Wan-Ting; Yang, Hung-Chih; Chen, Chi-Ling; Su, Tung-Hung; Kao, Jia-Horng | J. Gastroenterol. Hepatol. | | | |
2015 | The NIACE score helps predict the survival of Asian hepatocellular carcinoma patients | Su, Tung-Hung; Liu, Chun-Jen; Yang, Hung-Chih; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Adhoute, Xavier; Bourliere, Marc; Kao, Jia-Horng | J. Gastroenterol. Hepatol. | | | |
2015 | The NIACE score helps predict the survival of Asian hepatocellular carcinoma patients | Su, Tung-Hung; Liu, Chun-Jen; Yang, Hung-Chih; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Adhoute, Xavier; Bourliere, Marc; Kao, Jia-Horng | J. Gastroenterol. Hepatol. | | | |
2004 | 二維水深平均束縮渠道流場之解析 | 蘇騰鋐; Su, Tung-Hung | | | | |
2015 | 分子標靶治療藥物在肝纖維化進展之療效 | 蘇東弘; Su, Tung-Hung | | | | |